Study characteristics of the British Childhood Cancer Survivor Study
| Patient characteristic | Respiratory death | % | Other death | % | Total |
| Overall | 164 | 3.7 | 4311 | 96.3 | 4475 |
| Sex | |||||
| Male | 98 | 3.7 | 2531 | 96.3 | 2629 |
| Female | 66 | 3.6 | 1780 | 96.3 | 1848 |
| First primary neoplasm type | |||||
| CNS tumour (excluding PNET) | 68 | 5.3 | 1223 | 94.7 | 1291 |
| CNS PNET | 15 | 4.4 | 326 | 95.6 | 341 |
| Leukaemia (excluding AML) | 23 | 2.1 | 1080 | 97.9 | 1103 |
| AML | 3 | 3.7 | 79 | 96.3 | 82 |
| Hodgkin’s lymphoma | 7 | 2.1 | 324 | 97.9 | 331 |
| Non-Hodgkin’s lymphoma | 5 | 3.8 | 126 | 96.2 | 131 |
| Neuroblastoma | 6 | 4.2 | 138 | 95.8 | 144 |
| Non-heritable retinoblastoma | 1 | 3.2 | 30 | 96.8 | 31 |
| Heritable retinoblastoma | 4 | 2.9 | 134 | 97.1 | 138 |
| Wilms | 7 | 3.8 | 177 | 96.2 | 184 |
| Bone sarcoma | 1 | 0.5 | 197 | 99.5 | 198 |
| Soft tissue sarcoma | 11 | 4.3 | 242 | 95.7 | 253 |
| Germ cell tumours | 8 | 10.7 | 67 | 89.3 | 75 |
| Other | 5 | 2.9 | 168 | 97.1 | 173 |
| Age at diagnosis (years) | |||||
| Mean | 7.3 | 7.3 | 7.3 | ||
| 0–4 | 64 | 3.9 | 1597 | 96.1 | 1661 |
| 5–9 | 43 | 3.2 | 1309 | 96.8 | 1352 |
| 10–14 | 57 | 3.9 | 1405 | 96.1 | 1462 |
| Treatment era | |||||
| 1940–1969 | 61 | 4.6 | 1268 | 95.4 | 1329 |
| 1970–1979 | 48 | 3.8 | 1199 | 96.2 | 1247 |
| 1980–1989 | 36 | 3.8 | 905 | 96.2 | 941 |
| 1990–2006 | 19 | 2.0 | 939 | 98.0 | 958 |
| Years from diagnosis | |||||
| Mean | 24.7 | 16.7 | 17.0 | ||
| 5–9 | 36 | 1.7 | 2022 | 98.3 | 2058 |
| 10–19 | 33 | 3.1 | 1028 | 96.9 | 1061 |
| 20–29 | 33 | 6.0 | 515 | 94.0 | 548 |
| 30–39 | 32 | 7.6 | 390 | 92.4 | 422 |
| 40–49 | 21 | 7.6 | 256 | 92.4 | 277 |
| 50–59 | 8 | 7.7 | 96 | 92.3 | 104 |
| 60+ | 1 | 5.9 | 16 | 94.1 | 17 |
| Attained age at exit (years) | |||||
| Mean | 32.0 | 24.0 | 24.3 | ||
| 5–9 | 7 | 1.7 | 409 | 98.3 | 416 |
| 10–19 | 37 | 2.0 | 1797 | 98.0 | 1834 |
| 20–29 | 35 | 3.5 | 970 | 96.5 | 1005 |
| 30–39 | 34 | 6.3 | 502 | 93.7 | 536 |
| 40–49 | 27 | 7.3 | 341 | 92.7 | 368 |
| 50–59 | 20 | 8.4 | 218 | 91.6 | 238 |
| 60+ | 4 | 4.4 | 86 | 95.6 | 90 |
AML, acute myeloid leukaemia; CNS, central nervous system; PNET, primitive neuroectodermal tumour.